肝硬化心肌病:一个永远是话题的主题
Mona Boudabbous1,2, Rania Hammemi3,2, Hela Gdoura1,2
1Gastroenterology Department, Hédi Chaker Hospital, Sfax, Tunisia.
Future science OA
|May 31, 2024
概括
肝硬化,肝纤维化的晚期,可以导致肝硬化心肌病. 这种沉默的心脏病缺乏特定的治疗方法,管理方式与标准的心力衰竭护理相匹配.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
背景情况:
- 肝硬化代表肝纤维化的晚期阶段,其特点是显著的血液动力学变化和高动力循环.
- 肝硬化心肌病 (CC) 是肝硬化的心脏并发症,通常在疾病晚期之前没有症状.
- 目前对CC机制的理解尚不完整,目前还没有针对性的治疗方法.
研究的目的:
- 审查目前对肝性心肌病的理解和诊断标准.
- 讨论肝硬化心肌病的管理策略.
- 突出需要进一步研究CC的特定治疗方法.
主要方法:
- 对最近的研究和关于肝硬化心肌病的指南的文献综述.
- 基于心力衰竭概念的建议诊断标准的分析.
- 对CC的当前管理方法的综合.
主要成果:
- 已经提出了诊断心力衰竭的新标准,与现代心力衰竭知识保持一致.
- 尽管有机理性的见解,但针对CC的特定治疗方法仍然不可用.
- 症状性CC治疗遵循左心室衰竭的一般原则.
结论:
- 肝硬化心肌病是晚期肝病的重要并发症.
- 目前的管理重点是缓解症状和一般心力衰竭协议.
- 进一步的研究对于开发针对CC的向治疗是必不可少的.
相关概念视频
Cardiomyopathy I: Introduction and Classification
828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy
957
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Cirrhosis I: Introduction
30
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
30


